IDBS, a global provider of data management,
analytics, and modeling solutions, announced that King’s Health Partners has
deployed the Oncology Research Information System (ORIS), a platform that
consolidates translational medicine data from multiple sites into one system.
ORIS will help uncover new avenues for research into cancer causes and
personalized treatments to improve outcomes for patients in London
and advance cancer research in the U.K.
ORIS is based on the IDBS Enterprise
Translational Medicine Solution, a product that supports cross organization translational
medicine research, accelerating development of personalized treatments. The
initial ORIS deployment allows King’s Health Partners to combine clinical,
genetic, and tissue sample data across more than 26,000 historic breast cancer
patients alongside a current feed of new, consented patients’ data direct from
the clinic into the longitudinal research database.
ORIS also creates a resource for pharmaceutical,
biotechnology, and diagnostic companies who are interested in collaborations in
cancer research. The platform can identify patient cohorts—with similar disease
characteristics—whose treatment, genetic profiles, and outcomes can be followed
while retaining complete patient confidentiality.
IDBS – www.idbs.com